TICKERNOMICS Sign up
Last Update: 2023-12-23 06:04:34
PAINREFORM LTD. ( PRFX ) https://www.painreform.com
2.53USD
Sector:
Healthcare
Industry:
Drug Manufacturers-Specialty & Generic
Country:
Israel
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-29.84%
PRFX
SPY
30.72%
-94.62%
PRFX
SPY
112.82%
PRFX
0.00%
SPY
201.04%
PRFX
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
3.18
2.15
0.02
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.42
36.93
0.37
-223.46
0.00
-0.23
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-2809.30
100.00
-2670.35
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
3.86
-35.11
-49.84
0.00
Other Earnings and Cash Flow Stats:
PAINREFORM LTD. ( PRFX ) Net Income TTM ($MM) is -7.43
PAINREFORM LTD. ( PRFX ) Operating Income TTM ($MM) is -9.12
PAINREFORM LTD. ( PRFX ) Owners' Earnings Annual ($MM) is 0.00
PAINREFORM LTD. ( PRFX ) Current Price to Owners' Earnings ratio is 0.00
PAINREFORM LTD. ( PRFX ) EBITDA TTM ($MM) is -8.95
PAINREFORM LTD. ( PRFX ) EBITDA Margin is -2670.35%
Capital Allocation:
PAINREFORM LTD. ( PRFX ) has paid 0.00 dividends per share and bought back -0.158279 million shares in the past 12 months
PAINREFORM LTD. ( PRFX ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
PAINREFORM LTD. ( PRFX ) Interest-bearing Debt ($MM) as of last quarter is 0
PAINREFORM LTD. ( PRFX ) Annual Working Capital Investments ($MM) are 0
PAINREFORM LTD. ( PRFX ) Book Value ($MM) as of last quarter is 8
PAINREFORM LTD. ( PRFX ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
PAINREFORM LTD. ( PRFX ) has 7 million in cash on hand as of last quarter
PAINREFORM LTD. ( PRFX ) has 1 million of liabilities due within 12 months, and long term debt 0 as of last quarter
PAINREFORM LTD. ( PRFX ) has 1 common shares outstanding as of last quarter
PAINREFORM LTD. ( PRFX ) has 0 million USD of preferred stock value
Academic Scores:
PAINREFORM LTD. ( PRFX ) Altman Z-Score is -5.62 as of last quarter
PAINREFORM LTD. ( PRFX ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
PAINREFORM LTD. ( PRFX ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of PAINREFORM LTD. ( PRFX ) for the amount of $ on
5.47% of PAINREFORM LTD. ( PRFX ) is held by insiders, and 21.48% is held by institutions
PAINREFORM LTD. ( PRFX ) went public on 2020-09-01
Other PAINREFORM LTD. ( PRFX ) financial metrics:
FCF:-6.91
Unlevered Free Cash Flow:0.00
EPS:0.12
Operating Margin:-2809.30
Gross Profit Margin:100.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:1.67
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About PAINREFORM LTD. ( PRFX ) :
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.